Top Investment Opportunities
from NY’s Digital Health & Biotechnology Community
11:00am - 4:30pm | Rise | 43 West 23rd Street
NYC is home to cutting edge startups, massive investment dollars and a diverse ecosystem, including universities and academic medical centers.
250 inventions * $1Bn Dollars Invested Across 63 Deals * 300 License Agreements * $1.1Bn in IP Revenues
Karen Ignagni, CEO, EmblemHealth
Donato Tramuto, CEO, Tivity Health
Lindsay Jurist-Rosner, CEO, Wellthy (moderator)
What will the CEO of the future look like? Leadership is not just about meeting financial expectations, it's also about leading a company with compassion and purpose – wise business leaders understand that a strong culture of employee acceptance is essential to a productive, fruitful and resilient business.
The Massive Play Across Content, B2C and Cracking the B2B Landscape
Katherine Ryder, CEO, Maven
Chaim Indig, CEO, Phreesia
Jay Parkinson, Founder, Sherpaa
Samer Hamadeh, CEO, Zeel
Derek Flanzraich, CEO, Greatist
Scott Styles, Managing Director, FTI Consulting (Moderator)
Health represents the second fastest growing on-demand segment. And, consumers aren't the only ones getting in on the action.
Technology Innovations & How to Partner
Sree Kant, Head of External Partnering, Pfizer
Bob Silverman, PHC Business Strategy & Partnering, Diagnostics, Roche
Clark Golestani, Former President, Emerging Businesses and Global CIO (retired) Merck
Randy Sunberg, Partner, Morgan Lewis (Moderator)
Among other topics, this session will cover:
Raising Money, Valuations & Identifying Winners – The Investors' Perspective
Gregg Michaelson, Partner, Edison Ventures
Adam Dakin, Partner, DreamIt Ventures
Michael Greeley, Partner, Flare Capital
Stacey Seltzer, Partner, Aisling Capital
Evan Smith, Managing Director, FTI Consulting (Moderator)
Eric Marcotulli, CEO, Elysium Health
Robert Johnston, CEO, Executive Council / NYVCA (Moderator)
Building a company from the ground up is hugely difficult (as every founder knows). And, truly disruptive models simply can't exist in the traditional healthcare constructs. In the "Wellness" category, there are dozens and dozens of companies pursuing prevention and proactivity.
The public and private investment required to build a proper Life Sciences ecosystem in NYC
Michael Aberman, CEO, Quentis
Ed Rosen, CEO, Elucida Oncology
Sonia Gulati, Asst. Director, New York Ventures, Empire State Development Corporation
Doug Thiede, SVP Life Sciences & Healthcare, New York City Economic Development Corporation
Andre Moura, Managing Director, New Mountain Capital
Mark Sodano, Managing Partner, Tri-State Life Sciences Practice Leader, Deloitte (Moderator)
What You Need to Know Now in Data, AI & Machine Learning
Sundeep Bhan, CEO, Prognos
Dr. Thomas Fuchs, CEO, PAIGE.ai
Adam Hanina, CEO, AiCure
Fred Nazem, CEO, Rejuvenan
Alex Bisignano CEO, Phosphorus
Peter Micca, Managing Partner, National Healthtech Practice Leader, Deloitte (Moderator)
All facets of healthcare are being massively disrupted by AI and machine learning. The patient journey at home, in the waiting room, at the point of care and even billing and follow up are all areas that are feeling the innovative weight of AI and machine learning.
HBTS is a great opportunity to showcase all of the best technology coming out of New York City. I look forward to the next event.
General Partner Founder & CEO, Filament
VentriNova has benefited a great deal from our association with the Summit. Our presentation put us in front of New York’s biotech community so that we could tell our unique story of being the only company in the world that has demonstrated the ability to make de novo heart muscle cells in diseased heart tissue with a significant improvement in heart function. And, we met and recruited our CEO from [HBTS's] Executive-in-Residence Program!
Dr. Hina Chaudhry
The Summit provides the ideal venue to discuss and refine our strategy by interacting with seasoned entrepreneurs and subject-matter experts. Beyond the main event, the support from the ETS/Tech Connect team translated into numerous connections to potential investors and had a direct impact on our fundraising process. Currently no other biotech-related program in NYC can provide that value and breadth of support to life sciences entrepreneurs.
Co-Founder at Repairogen
If you’d like to speak at one of future events, please get in touch.
Potential Sponsor? Speaker? Questions? Get in touch.